Baidu
map

2022 国际共识建议:CDKL5 缺乏症患者的评估和管理

2022-06-20 国外神经内科相关专家小组(统称) Front Neurol.2022 Jun 20;13:874695.

CDKL5缺乏症(CDD)是一种罕见的神经发育障碍,由位于X染色体上的CDKL5基因突变引起 。本文主要针对CDKL5 缺乏症患者的评估和管理提出了共识指导建议。

中文标题:

2022 国际共识建议:CDKL5 缺乏症患者的评估和管理

英文标题:

International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder

发布日期:

2022-06-20

简要介绍:

CDKL5缺乏症(CDD)是一种罕见的神经发育障碍,由位于X染色体上的CDKL5基因突变引起 。本文主要针对CDKL5 缺乏症患者的评估和管理提出了共识指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=fneur-13-874695.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d89131c00251a05c, title=2022 国际共识建议:CDKL5 缺乏症患者的评估和管理, enTitle=International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder, guiderFrom=Front Neurol.2022 Jun 20;13:874695., authorId=0, author=, summary=CDKL5缺乏症(CDD)是一种罕见的神经发育障碍,由位于X染色体上的CDKL5基因突变引起 。本文主要针对CDKL5 缺乏症患者的评估和管理提出了共识指导建议。, cover=https://img.medsci.cn/Random/medical-stethoscope-and-electronics-PZX4HPS.jpg, journalId=0, articlesId=null, associationId=952, associationName=国外神经内科相关专家小组(统称), associationIntro=null, copyright=0, guiderPublishedTime=Mon Jun 20 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">CDKL5缺乏症(CDD)是一种罕见的神经发育障碍,由位于X染色体上的CDKL5基因突变引起 。本文主要针对CDKL5 缺乏症患者的评估和管理提出了共识指导建议。</span></p>, tagList=[TagDto(tagId=10637, tagName=罕见病), TagDto(tagId=27996, tagName=国际共识), TagDto(tagId=437578, tagName=CDKL5缺乏症)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=304, categoryName=罕见病, tenant=100), CategoryDto(categoryId=21072, categoryName=罕见病网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=437578, articleKeyword=CDKL5缺乏症, articleKeywordNum=6, guiderKeywordId=27996, guiderKeyword=国际共识, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7494, appHits=26, showAppHits=0, pcHits=382, showPcHits=7468, likes=0, shares=3, comments=1, approvalStatus=1, publishedTime=Mon Jul 11 21:28:00 CST 2022, publishedTimeString=2022-06-20, pcVisible=1, appVisible=1, editorId=0, editor=lixiang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=8, createdBy=null, createdName=lixiang, createdTime=Fri Jul 08 12:18:18 CST 2022, updatedBy=6459136, updatedName=艺玮, updatedTime=Sat Jan 06 19:16:12 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=fneur-13-874695.pdf)])
fneur-13-874695.pdf
下载请点击:
评论区 (1)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2089259, encodeId=5642208925944, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=303b5647482, createdName=ms7000001795743421, createdTime=Tue Sep 20 09:04:32 CST 2022, time=2022-09-20, status=1, ipAttribution=)]
    2022-09-20 ms7000001795743421

    学习

    0

拓展阅读

发育性癫痫性脑病:CDKL5缺乏症(CDD)

介绍了 CDKL5 综合征,包括其基因、发病机制、临床表现、诊断方法、治疗药物及预后。指出其为常见 DEE 类型,相关疗法获批,预后与突变位点等相关。

Lancet Neurol:Ganaxolone治疗CDKL5缺乏症的疗效

Ganaxolone能显著降低CCD相关癫痫发作的频率

2021 ISHLT共识文件:慢性血栓栓塞性肺动脉高压的评估和管理

国际心肺移植协会(ISHLT,The International Society of Heart and lung Transplantantion) · 2021-08-03

Baidu
map
Baidu
map
Baidu
map